Cargando…
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases
Neovascular age-related macular degeneration (AMD) is a progressive eye disease and is a leading cause of vision loss in the Western world. Vascular endothelial growth factor inhibitors have become a mainstay of treatment for this disease. Currently, treatment options include three originator biolog...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863367/ https://www.ncbi.nlm.nih.gov/pubmed/35211322 http://dx.doi.org/10.1093/jlb/lsac001 |